Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Shares Issued (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Shares Issued for 5 consecutive years, with $709152.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Issued changed N/A to $709152.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.5 million, a 29.75% decrease, with the full-year FY2024 number at $2.4 million, down 73.12% from a year prior.
  • Shares Issued was $709152.0 for Q3 2025 at Ensysce Biosciences, up from -$709151.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $7.5 million in Q2 2021 to a low of -$7.5 million in Q3 2021.
  • A 4-year average of $1.7 million and a median of $1.1 million in 2025 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: surged 1717.64% in 2021, then plummeted 46.99% in 2025.
  • Ensysce Biosciences' Shares Issued stood at $6.4 million in 2021, then dropped by 0.04% to $6.4 million in 2023, then crashed by 94.37% to $357861.0 in 2024, then soared by 98.16% to $709152.0 in 2025.
  • Per Business Quant, the three most recent readings for ENSC's Shares Issued are $709152.0 (Q3 2025), -$709151.0 (Q2 2025), and $1.1 million (Q1 2025).